A Study to Assess Safety & Effectiveness of Tovinontrine in Chronic Heart Failure With Reduced Ejection Fraction (Cycle-1-REF)
Clinical trial NCT06215911 · COMPLETED
Trial details
- NCT number
- NCT06215911
- Sponsor
- Cardurion Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-02-13
- Primary completion
- 2025-10-10
- Enrollment
- 557
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.